GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Caplin Point Laboratories Ltd (NSE:CAPLIPOINT) » Definitions » Shiller PE Ratio

Caplin Point Laboratories (NSE:CAPLIPOINT) Shiller PE Ratio : 54.52 (As of May. 21, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Caplin Point Laboratories Shiller PE Ratio?

As of today (2025-05-21), Caplin Point Laboratories's current share price is ₹2127.00. Caplin Point Laboratories's E10 for the quarter that ended in Mar. 2025 was ₹39.01. Caplin Point Laboratories's Shiller PE Ratio for today is 54.52.

The historical rank and industry rank for Caplin Point Laboratories's Shiller PE Ratio or its related term are showing as below:

NSE:CAPLIPOINT' s Shiller PE Ratio Range Over the Past 10 Years
Min: 23.67   Med: 40.27   Max: 72.36
Current: 55.36

During the past years, Caplin Point Laboratories's highest Shiller PE Ratio was 72.36. The lowest was 23.67. And the median was 40.27.

NSE:CAPLIPOINT's Shiller PE Ratio is ranked worse than
85.36% of 526 companies
in the Drug Manufacturers industry
Industry Median: 25.185 vs NSE:CAPLIPOINT: 55.36

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Caplin Point Laboratories's adjusted earnings per share data for the three months ended in Mar. 2025 was ₹18.700. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₹39.01 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Caplin Point Laboratories Shiller PE Ratio Historical Data

The historical data trend for Caplin Point Laboratories's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caplin Point Laboratories Shiller PE Ratio Chart

Caplin Point Laboratories Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.63 34.98 23.67 41.35 51.27

Caplin Point Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.35 43.55 52.88 66.52 51.27

Competitive Comparison of Caplin Point Laboratories's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Caplin Point Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Caplin Point Laboratories's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Caplin Point Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Caplin Point Laboratories's Shiller PE Ratio falls into.


;
;

Caplin Point Laboratories Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Caplin Point Laboratories's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=2127.00/39.01
=54.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Caplin Point Laboratories's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, Caplin Point Laboratories's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=18.7/157.5517*157.5517
=18.700

Current CPI (Mar. 2025) = 157.5517.

Caplin Point Laboratories Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201506 1.678 99.841 2.648
201509 0.372 101.753 0.576
201512 2.130 102.901 3.261
201603 2.062 102.518 3.169
201606 2.136 105.961 3.176
201609 0.598 105.961 0.889
201612 3.150 105.196 4.718
201703 4.410 105.196 6.605
201706 4.790 107.109 7.046
201709 4.690 109.021 6.778
201712 4.940 109.404 7.114
201803 4.740 109.786 6.802
201806 4.920 111.317 6.964
201809 6.180 115.142 8.456
201812 6.030 115.142 8.251
201903 6.550 118.202 8.731
201906 6.460 120.880 8.420
201909 7.510 123.175 9.606
201912 7.680 126.235 9.585
202003 6.410 124.705 8.098
202006 7.150 127.000 8.870
202009 7.460 130.118 9.033
202012 8.460 130.889 10.183
202103 8.640 131.771 10.330
202106 9.250 134.084 10.869
202109 9.860 135.847 11.435
202112 9.810 138.161 11.187
202203 10.340 138.822 11.735
202206 11.120 142.347 12.308
202209 11.990 144.661 13.058
202212 12.845 145.763 13.884
202303 13.453 146.865 14.432
202306 13.550 150.280 14.206
202309 15.060 151.492 15.662
202312 15.390 152.924 15.856
202403 15.900 153.035 16.369
202406 16.240 155.789 16.424
202409 17.120 157.882 17.084
202412 18.190 158.323 18.101
202503 18.700 157.552 18.700

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Caplin Point Laboratories  (NSE:CAPLIPOINT) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Caplin Point Laboratories Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Caplin Point Laboratories's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Caplin Point Laboratories Business Description

Traded in Other Exchanges
Address
Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096
Caplin Point Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, injections (liquid and lyophilized, prefilled syringes), ophthalmic solutions, liquid orals, soft gel capsules, ointments, creams, gels, powders for injections, suppositories, ovules, pre-mix bag formulations, inhalers, sprays, and IV infusions. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops.

Caplin Point Laboratories Headlines

No Headlines